Lothar Germeroth
Chief Executive Officer at Juno Therapeutics GmbH
Lothar Germeroth active positions
Companies | Position | Start | End |
---|---|---|---|
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Chief Executive Officer | - | - |
Repairon GmbH
Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. | Chief Executive Officer | 2023-09-14 | - |
Chairman | 2013-12-31 | - | |
Founder | 2013-12-31 | - |
Career history of Lothar Germeroth
Former positions of Lothar Germeroth
Companies | Position | Start | End |
---|---|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
IBA GmbH
IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Chief Executive Officer | - | - |
Human Resources Officer | 2002-03-31 | - |
Training of Lothar Germeroth
Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
Johann Wolfgang Goethe-Universität Frankfurt am Main | Undergraduate Degree |
Statistics
International
Germany | 6 |
Switzerland | 2 |
Operational
Chief Executive Officer | 3 |
Human Resources Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
IBA GmbH
IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany. | Health Services |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Health Technology |
Repairon GmbH
Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. |
- Stock Market
- Insiders
- Lothar Germeroth
- Experience